Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI)

Thursday’s trading has closed, but OGXI is being traded in the after-hours session. After-Hours quote »
3.24
Delayed Data
As of 3:59pm ET
 +0.02 / +0.62%
Today’s Change
1.74
Today|||52-Week Range
4.10
+41.48%
Year-to-Date

Today’s Trading

Previous close3.22
Today’s open3.32
Day’s range3.05 - 3.39
Volume832,007
Average volume (3 months)675,363
Market cap$76.5M
Dividend yield--
Data as of 3:59pm ET, 07/30/2015

Growth & Valuation

Earnings growth (last year)+33.18%
Earnings growth (this year)+33.79%
Earnings growth (next 5 years)--
Revenue growth (last year)-9.26%
P/E ratioNM
Price/Sales1.53
Price/Book2.14

Competitors

 Today’s
change
Today’s
% change
ORMPOramed Pharmaceutica...-0.19-2.86%
OCRXOcera Therapeutics I...-0.06-1.54%
EYEGEyeGate Pharmaceutic...0.00--
APRIApricus Biosciences ...-0.06-4.03%
Data as of 3:59pm ET, 07/30/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)$0.41
Annual revenue (last year)$27.1M
Annual profit (last year)-$26.2M
Net profit margin-96.77%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Secretary, Treasurer &
Director
Scott Daniel Cormack
Chief Financial Officer &
Vice President
John A. Bencich
Corporate headquarters
Bothell, Washington

Forecasts